Cwm, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Cwm, LLC
- $23.3 Billion
- Q3 2024
A detailed history of Cwm, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 9,298 shares of CPRX stock, worth $197,768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,298
Previous 4,066
128.68%
Holding current value
$197,768
Previous $63,000
193.65%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding CPRX
# of Institutions
326Shares Held
94MCall Options Held
19.1KPut Options Held
51.1K-
Black Rock Inc. New York, NY18.7MShares$398 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.04MShares$171 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$133 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$121 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$64.2 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.19B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...